Kala Pharmaceuticals Inc.

NASDAQ: KALA · Real-Time Price · USD
8.13
0.06 (0.74%)
At close: Aug 15, 2025, 10:08 AM

Kala Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
51.18M 50.9M 70.5M 92.14M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
246K 301K 462K 1.46M
Other Long-Term Assets
n/a n/a n/a 9.58M
Receivables
n/a 236K 6.5M 17.45M
Inventory
n/a n/a 7.67M 8.64M
Other Current Assets
1.62M 1.06M 580K 5.22M
Total Current Assets
52.8M 52.87M 85.94M 124.37M
Property-Plant & Equipment
2.44M 2.78M 416K 4.02M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.69M 3.08M 878K 15.06M
Total Assets
55.48M 55.95M 86.82M 139.43M
Account Payables
628K 919K 2.35M 2.78M
Deferred Revenue
637K 1.07M 4.19M 28M
Short-Term Debt
10.34M 334K 5.01M 711K
Other Current Liabilities
2.39M 2.28M 10.79M -1.1M
Total Current Liabilities
16.96M 8.35M 25.68M 37.42M
Long-Term Debt
20.1M 34.19M 37.94M 78.93M
Other Long-Term Liabilities
4.66M 4.11M 4.22M 5.72M
Total Long-Term Liabilities
26.2M 40.1M 42.16M 85.2M
Total Liabilities
43.15M 48.45M 67.85M 122.62M
Total Debt
32.25M 36.32M 42.95M 80.19M
Common Stock
6K 3K 2K 66K
Retained Earnings
-667.92M -629.41M -587.21M -542.39M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
12.33M 7.5M 18.97M 16.8M
Total Investments
246K 301K 462K 1.46M